Scientific Sense ®

The start-up ecosystem in life sciences, Stakeholders in a start-up, Basic v/s translational research, and health systems  Mr. Jim Jordan is the President of the Pittsburgh Life Sciences Greenhouse and the Managing Director of the Accelerator Funds. Jim has served as a Distinguished Service Professor of Healthcare & Biotechnology Management at Carnegie Mellon University. He has written two books; Innovation, Commercialization, and Start-ups in Life Sciences, The Intellectual Property Pyramid Assessment, and is currently working on his third book, Health Systems.

Adaptive control for COVID-19 in India, A field experiment for health insurance in India, the evolution of influenza with vaccination Prof Anup Malani is a Professor at the University of Chicago Law School and a Professor at the Pritzker School of Medicine at the University of Chicago.  He is also a Research Associate at the National Bureau of Economic Research in Boston, a Senior Fellow at the Schaeffer Center at the University of Southern California, and an editor at the Journal of Law and Economics. Prof. Malani is the co-founder and Faculty Director of the International Innovation Corps, a social service program that sends teams of US and foreign university graduates to work on innovative development projects with government officials in India.

Battery technologies, species of electrolytes, materials science innovation, the safety of products, and the need for inclusion in education Prof. Steve Greenbaum is a Professor of Physics at Hunter College in the City University of New York and a Fellow of the American Physical Society. Prof. Greenbaum's main research interest involves spectroscopic studies of disordered solids by magnetic resonance and synchrotron x-ray absorption, most of which have recently centered on materials for electrochemical energy storage and conversion. He has authored or co-authored over 260 peer-reviewed publications and given over 60 invited talks at national or international conferences.

Pharmaceutical R&D trends and costs, Value chain paradigms, Basic v/s translational research, Investment needs, and COVID 19 Prof. Kenneth Kaitin is a professor of Public Health and Medicine at Tufts School of Medicine and the Director of the Tufts Center for the Study of Drug Development. He is also an Advisory Professor at Shanghai Medical College at Fudan University in Shanghai, and a consultant to the U.S. Department of Defense on bioterror countermeasures. Ken’s research focuses on the economic, scientific, regulatory, and political factors that affect pharmaceutical development.

Future of business law, Corporate legal strategy, Turning compliance into a competitive advantage Prof. Robert Bird is a Professor of Business Law and the Chair in Business Ethics at the University of Connecticut. Robert's wide-ranging research focuses on corporate social responsibility, corporate compliance, employment law, legal strategy, and the intersection of law and business. His work has been published widely and he has received numerous teaching and research awards and is currently the President-Elect of the Academy of Legal Studies in Business.

Investment-q paradox,  persistent investment decline, Tobin's q decomposition, asset utilization as a driver of investment rate, and failure of common explanations.   Prof. David Ikenberry was the Chair of Finance at the University of Illinois at Urbana-Champaign and the Associate Dean of the Executive programs. Later he served as the Dean of the Leeds School of Business at the University of Colorado, Boulder, and now serves as the full professor in the School. He was an early pioneer among researchers examining long-horizon stock returns, particularly returns subsequent to major corporate news events. Much of his work relates to behavioral finance and the extent to which news is incorporated into market prices. His most noted work has studied open market stock repurchase programs. Please excuse the slight overlap in the audio.

Alzheimer's disease, oxidative stress, mitochondria abnormalities, diagnostics, amyloid-beta plaques, aging Prof. George Perry is a Professor of Biology and Chemistry at The University of Texas at San Antonio. Prof Perry is recognized in the field of Alzheimer's disease research particularly for his work on oxidative stress.  Perry's research is primarily focused on how Alzheimer’s disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of increased oxygen radicals.

Artificial Intelligence, Breast cancer diagnostics, Teleradiology, Social return to technology commercialization  Prof. Richard Mammone, a professor of engineering and business at Rutgers University. He is a fellow of the National Academy of Inventors, recipient of the Thomas Edison Patent Award and inductee of the New Jersey Inventors Hall of Fame. He has published over 200 papers and has 30 patents. He was a founding editorial board member of the IEEE Neural Network Society and was the Associate Vice President of Innovation and Partnerships of Rutgers.

Food, Nutrition, Obesity, supply chains, food security Marion Nestle is a Professor of Nutrition, Food Studies, and Public Health, at New York University. She is also a Visiting Professor of Nutritional Sciences at Cornell. Her research and writing examine scientific and socioeconomic influences on food choice and its consequences, emphasizing the role of food industry marketing. She is the author of six prize-winning books. She has received many awards and honors for her excellent teaching, research, and writing.

Public-private partnerships, education systems, ethics and leadership  Dr. Stanley Litow is a Professor at Columbia and Duke University, and serve as Innovator in Residence at Duke. He is a speaker, writer and subject matter expert on Education and Corporate Social Responsibility and had a career in the public, private and not for profit sectors, including President of the IBM Foundation, Deputy Schools Chancellor for New York City, and Founder of Interface. He has served on several Presidential Commissions and currently serves as a Trustee of the State University of New York. He is also a columnist for Barron's.